Surgery Partners EBITDA Margin 2013-2025 | SGRY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surgery Partners (SGRY) over the last 10 years. The current EBITDA margin for Surgery Partners as of March 31, 2025 is .
| Surgery Partners EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $3.17B | $0.51B | 16.14% |
| 2024-12-31 | $3.11B | $0.52B | 16.70% |
| 2024-09-30 | $2.98B | $0.49B | 16.39% |
| 2024-06-30 | $2.89B | $0.49B | 16.90% |
| 2024-03-31 | $2.79B | $0.49B | 17.50% |
| 2023-12-31 | $2.74B | $0.46B | 16.77% |
| 2023-09-30 | $2.72B | $0.45B | 16.61% |
| 2023-06-30 | $2.66B | $0.44B | 16.60% |
| 2023-03-31 | $2.61B | $0.42B | 16.25% |
| 2022-12-31 | $2.54B | $0.47B | 18.59% |
| 2022-09-30 | $2.44B | $0.48B | 19.82% |
| 2022-06-30 | $2.38B | $0.47B | 19.75% |
| 2022-03-31 | $2.31B | $0.45B | 19.54% |
| 2021-12-31 | $2.22B | $0.41B | 18.57% |
| 2021-09-30 | $2.16B | $0.40B | 18.41% |
| 2021-06-30 | $2.10B | $0.35B | 16.77% |
| 2021-03-31 | $1.93B | $0.34B | 17.35% |
| 2020-12-31 | $1.86B | $0.29B | 15.54% |
| 2020-09-30 | $1.83B | $0.26B | 14.22% |
| 2020-06-30 | $1.79B | $0.29B | 16.47% |
| 2020-03-31 | $1.86B | $0.30B | 16.17% |
| 2019-12-31 | $1.83B | $0.32B | 17.64% |
| 2019-09-30 | $1.81B | $0.20B | 10.86% |
| 2019-06-30 | $1.79B | $0.18B | 10.08% |
| 2019-03-31 | $1.78B | $0.17B | 9.34% |
| 2018-12-31 | $1.77B | $0.16B | 8.75% |
| 2018-09-30 | $1.74B | $0.29B | 16.49% |
| 2018-06-30 | $1.61B | $0.23B | 14.50% |
| 2018-03-31 | $1.47B | $0.22B | 14.95% |
| 2017-12-31 | $1.34B | $0.22B | 16.12% |
| 2017-09-30 | $1.19B | $0.19B | 16.10% |
| 2017-06-30 | $1.16B | $0.24B | 20.29% |
| 2017-03-31 | $1.17B | $0.25B | 21.63% |
| 2016-12-31 | $1.15B | $0.24B | 21.12% |
| 2016-09-30 | $1.10B | $0.20B | 17.95% |
| 2016-06-30 | $1.06B | $0.20B | 18.68% |
| 2016-03-31 | $1.00B | $0.19B | 18.54% |
| 2015-12-31 | $0.96B | $0.19B | 19.69% |
| 2015-06-30 | $0.53B | $0.12B | 22.70% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.813B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.035B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Caris Life Sciences,�Inc (CAI) | $6.821B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |